SCOPE 2023 ATTRACTS MORE THAN 3,200 PARTICIPANTS
In its 14th year, SCOPE Summit was attended by over 3,200 participants. The impressive executive audience at SCOPE came together for invaluable networking opportunities for four days, with more than 75% of the attendees titled as a decision-maker from leading Pharma (20%), Biotech companies (26%) and CRO (16%). Industry leaders and key decision-makers representing more than 1,000 unique organizations shared case studies, collaborated on best practices, and provided unique perspectives on poignant issues that the clinical research industry currently faces.
The 2023 program offered 29 distinct conferences, and four plenary keynote sessions, focused on addressing racial inequities in clinical trials, the reality of a trial experience, navigating a global crisis, next-gen data sources, and building a roadmap for a R&D organization. Program coverage included Site Selection and Management, Participant Engagement, Patient Recruitment and Retention, Diversity, Equity and Inclusion, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Sensors, Wearables, and Clinical Biomarkers, Risk-Based Monitoring, Post-Marketing Studies, Artificial Intelligence, Medical Devices, Observational Research, Clinical Supply Management, as well as COVID-19. SCOPE offered a new program this year, Clin Trial Tech: Venture, Innovation and Partnering conference, which was an exclusive gathering of the leading innovators, investors, and sponsors who are driving the future of clinical trials.
This year we also featured the Second Annual Masters of Clinical Research golf tournament, the Seventh Annual Participant Engagement Awards and the Inaugural Best of Show awards, which Recognizes Exceptional Innovation in Technologies Used By Clinical Research Professionals. In addition to every conference and event, participants were also part of a Guiness Book of World Records for the most people at one time wearing aviator glasses.
Mark your calendar for 2024
15th Annual SCOPE Summit 2024
February 11-14 | Rosen Shingle Creek
Orlando, Florida
Join SCOPE LinkedIn Group
Join ClinEco, our Global Clinical Trials Ecosystem and Marketplace
Subscribe to the SCOPE of Things Podcast
Hear what a few people had to say about SCOPE Summit 2023:
It was my first SCOPE Investor and Innovation Conference and it was such an eye-opening event to meet talents with very different background to discuss the achievement and future gaps in Clinical Research, Digital Health, Health Service Providers. The network opportunity is amazing!
— PhD, Managing Director, Boehringer Ingelheim Venture Fund
Nothing compares to bringing together startups, investors and ultimate acquirers/customers in a specific market. The SCOPE Investor track delivered this in spades for the clinical trial market.”
— Founder & Managing Partner, SPRIG Equity
It was truly a pleasure participating in this excellent SCOPE Investor and Innovation Conference. It was my first SCOPE experience and I will be back!
— Global Head, Healthcare + Life Sciences, Amazon Web Services LLC
The SCOPE 2023 conference marked an exciting inflection point for the clinical trial industry as the future of clinicaltrials is unfolding. With the caliber of tracks, sessions, speakers, panels resulting in timely and provocative topics, SCOPE has become an important meeting that can't be missed. I left the conference thinking about how much we as an industry have evolved, how much more there is to do and how SCOPE is a great meeting place for advancing the industry.
— Founder, Hawthorne Effect, Inc.
Software innovation in the clinical domain, and pharma more broadly, is one of our top priorities – SCOPE is a fantastic venue to get together with thought leaders, innovators, and of course our portfolio companies sharing our passion for the space”
— Vice President, Insight Partners
It was really worth the time and effort to come back to SCOPE after 7 years and I was just delighted to see the growth over these years. The sessions were informative, and the Exhibit hall filled with emerging and established organizations, many of whom I interacted with over the 4 days.
— Head, Clinical Partner Management
I really enjoyed SCOPE over the years. I have attended four times so far. The topics are innovative and cutting edge and it is cross functional.
— PhD, Senior Director and Head of Statistical Innovation Statistical Sciences and Analytics Data and
Statistical Sciences, Abbvie
This was my first SCOPE US and I enjoyed it very much – it was great to meet so many new people, connect names to faces and have thought-provoking discussions.
— Senior Director, AstraZeneca
I appreciate the opportunity provided to me to attend and present at SCOPE Summit. This is a wonderful event and I loved every bit of the ideas shared by the many speakers on the evolving landscape of clinical trials and also to hear from other therapeutic areas in the Lifesciences and BioPharma industry.
— Sr. Manager, Clinical Systems, Transcatheter Mitral & Tricuspid Therapies
The pleasure is all mine to participate as a chair and speaker at the Summit. I always learn so much about the current trends in clinical research and look forward to seeing new innovation.
— Clinical Research Project, NIH, NINDS
This was first time attending SCOPE for me and I was very impressed by the quality and breadth of topics discussed. I got great questions and excellent follow-up networking and requests for more data around patient engagement, and minorities recruitment. Several of people from audiences asked if they could see any follow-up data on these topics and the cancer moonshot project in general in the next SCOPE meeting.
— Program Director, Biorepositories and Biospecimen Research Branch (BBRB), Cancer Diagnosis
Program Division of Cancer Treatment and Diagnosis, National Cancer Institute
I wanted to thank you for the opportunity to attend SCOPE. It was a wonderful experience. I learned so much and left with so many ideas, connections,and a world record certificate.
— Clinical Research, Fordham School of Social Service
I wanted to express our sincerest thanks for all the hard work in organizing SCOPE. Your team’s professionalism, attention to detail, and commitment to excellence were evident throughout the event and it was an absolute pleasure to be a part of it!
— Product Marketing Manager, StudyKIK
THANK YOU!!!!! Such a fun event.The SCOPE conference was absolutely incredible this year. Thanks for the wonderful opportunity and looking forward to participating in the conference in 2024.
— Vice President, Clinical Site Start Up, Site Engagement, Trial Optimization, Takeda